Cytokine profile in severe gram-positive and gram-negative abdominal sepsis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Surbatovic, Maja ^a   Popovic, Nada ^b,c   Vojvodic, Danilo ^a   Milosevic, Ivan ^b,c   Acimovic, Gordana ^c   Stojicic, Milan ^b,c   Veljovic, Milic ^a   Jevdjic, Jasna ^d,e   Djordjevic, Dragan ^a   Radakovic, Sonja ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d CLINICAL CENTER KRAGUJEVAC   (Serbia)

^e University of Kragujevac Medical Faculty   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE;

ADULT; AGED; BACTEREMIA; BLOOD; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CYTOKINES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; ROC CURVE; SEPSIS; YOUNG ADULT;

EID: 84935827741     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11355     Document Type: Article

References (44)

1. Gaieski, D.F., Edwards, J.M., Kallan, M.J. & Carr, B.G. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41, 1167-1174 (2013).
2. Surbatovic, M. et al. Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma. Mediators Inflamm 2013, 362793 (2013).
3. Opal, S.M. & Cohen, J. Clinical Gram-positive sepsis: Does it fundamentally differ from Gram-negative bacterial sepsis? Crit Care Med 27, 1608-1616 (1999).
4. Carlet, J., Cohen, J., Calandra, T., Opal, S. & Masur, H. Sepsis: time to reconsider the concept. Crit Care Med 36, 964-966 (2008).
5. Wang, J., Roderiques, G. & Norcross, M.A. Control of Adaptive Immune Responses by Staphylococcus aureus through IL-10, PD-L1, and TLR2. Sci. Rep. 2, 606; DOI:10.1038/srep00606 (2012).
6. Kumar, H., Kawai, T. & Akira, S. Pathogen recognition by the innate immune system. Int Rev Immunol 30, 16-34 (2011).
7. Gao, H., Ewans, T.W. & Finney, S.J. Bench-to-bedside review: sepsis, severe sepsis and septic shock-does the nature of the infecting organism matter? Crit Care 12, 213 (2008).
8. Legrand, M., Klijn, E., Payen, D. & Ince, K. The response of the host microcirculation to bacterial sepsis: does the pathogen matter? J Mol Med 88, 127-133 (2010).
9. Buerke, M. et al. Staphylococcus aureus alpha toxin mediates polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Shock 17, 30-35 (2002).
10. Faure, E. et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 275, 11058-11063 (2000).
11. Coureuil, M. et al. Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science 325, 83-87 (2009).
12. Tamayo, E. et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw 22, 82-87 (2011).
13. Bjerre, A., Brusletto, B., Hoiby, A.E., Kierulf, P. & Brandtzaeg, P. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit Care Med 32, 433-438 (2004).
14. Hessle, C.C., Andersson, B. & Wold, A.E. Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes. Cytokine 30, 311-318 (2005).
15. Hessle, C.C., Andersson, B. & Wold, A.E. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while Gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 68, 3581-3586 (2000).
16. Mohamed, M.A., Cunningham-Rundles, S., Dean, C.R., Hammad, T.A. & Nesin, M. Levels of pro-inflammatory cytokines produced from cord blood in vitro are pathogen dependent and increased in comparison to adult controls. Cytokine 39, 171-177 (2007).
17. Fisher, C.J. Jr. et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med 21, 318-327 (1993).
18. Tang, Y. et al. Th1/Th2 cytokine profiles in G+ /G- bacteremia in pediatric hematology/oncology patients. Pediatr Blood Cancer 58, 50-54 (2012).
19. Xu, X. et al. Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock. Intensive Care Med 39, 319-326 (2013).
20. Finney, S.J., Leaver, S.K., Evans, T.W. & Burke-Gaffney, A. Differences in lipopolysaccharide- and lipoteichoic acid-induced cytokine/chemokine expression. Intensive Care Med 38, 324-332 (2012).
21. Raynor, L.L. et al. Cytokine screening identifies NICU patients with Gram-negative bacteremia. Pediatr Res 71, 261-266 (2012).
22. Feezor, R.J. et al. Molecular characterization of the acute inflammatory response to infections with Gram-negative versus Grampositive bacteria. Infect Immun 71, 5803-5813 (2003).
23. Iwadou, H. et al. Differential cytokine response in host defence mechanisms triggered by Gram-negative and Gram-positive bacteria and the roles of gabexate mesilate, a synthetic protease inhibitor. J Int Med Res 30, 99-108 (2002).
24. Bjork, L., Andersson, J., Ceska, M. & Andersson, U. Endotoxin and staphylococcus aureus enterotoxin induce different patterns of cytokines. Cytokine 4, 513-519 (1992).
25. Skovbjerg, S. et al. Gram-positive and Gram-negative bacteria induce different patterns of cytokine production in human mononuclear cells irrespective of taxonomic relatedness. J Interferon Cytokine Res 30, 23-32 (2010).
26. Barkman, C., Martner, A., Hessle, C. & Wold, A.E. Soluble bacterial constituents down-regulate secretion of IL-12 in response to intact Gram-positive bacteria. Microbes Infect 10, 1484-1493 (2008).
27. Vincent, J.L. et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34, 344-353 (2006).
28. Zahar, J.R. et al. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med 39, 1886-1895 (2011).
29. Cohen, J. A role for the micro-organism in the outcome from infection? A principle challenged. Crit Care Med 39, 2001-2002 (2011).
30. Zambon, M., Ceola, M., Almeida-de-Castro, R., Gullo, A. & Vinsent, J.L. Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care 23, 455-460 (2008).
31. Andaluz-Ojeda, D. et al. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 57, 332-336 (2012).
32. Herper, Y. et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis and septic shock. Eur J Clin Microbiol Infect Dis 25, 481-491 (2006).
33. Wang, C.H., Gee, M.J., Yang, C. & Su, Y.C. A new model for outcome prediction in intra-abdominal sepsis by the linear discriminant function analysis of IL-6 and IL-10 at different heart rates. J Surg Res 132, 46-51 (2006).
34. Surbatovic, M. & Radakovic, S. Tumor necrosis factor-alpha levels early in severe acute pancreatitis: is there predictive value regarding severity and outcome? J Clin Gastroeterol 47, 637-643 (2013).
35. Surbatovic, M. et al. Polymorphisms of genes encoding tumor necrosis factor-alpha, interleukin-10, cluster of differentiation-14 and interleukin-1ra in critically ill patients. J Crit Care 25, 542.e1-e8 (2010).
36. Martin, G.S., Mannino, D.M., Eaton, S. & Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348, 1546-1554 (2003).
37. Llewelyn, M.J. & Cohen, J. Tracking the microbes in sepsis: advancements in treatment bring challenges for microbial epidemiology. Clin Infect Dis 44, 1343-1348 (2007).
38. Cohen, J. Diagnosing sepsis: does the microbiology matter? Crit Care 12, 145 (2008).
39. Vincent, J.L., Opal, S.M., Marshall, J.C. & Tracey, K.J. Sepsis definitions: time for a change. Lancet 381, 774-775 (2013).
40. Surbatovic, M. et al. Immune response in severe infection: could life-saving drugs be potentially harmful? Scientific World Journal 2013, 961852 (2013).
41. Dellinger, R.P. et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 41, 580-637 (2013).
42. Moreno, R.P. et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 25, 686-696 (1999).
43. Le Gall, J.R., Lemeshow, S. & Saulnier, F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270, 2957-2963 (1993).
44. Knaus, W.A., Draper, E.A., Wagner, D.P. & Zimmerman, J.E. APACHE II: a severity of disease classification system. Crit Care Med 13, 818-829 (1985).